Liesl Eibschutz

Employment

• Institut Pasteur
  2018 - Present

Education

• Duke University
  2015 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (1)

• Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease.
  Cell chemical biology 2017 DOI: 10.1016/j.chembiol.2017.07.011
  +Save